UBS AM
CPXX

UBS AM’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

UBS AM’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,200
Closed -$398K – 2638
2016
Q2 		$398K Buy
+13,200
New +$268K ﹤0.01% 2079

UBS AM's CPXX Position: Q3 2016 in Review

UBS AM sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 13,200 shares — an estimated $398K sold.

UBS AM first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $398K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • UBS AM reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • UBS AM sold 13,200 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $398K.
  • UBS AM first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • UBS AM's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $398K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on UBS AM's 13F filing for Q3 2016, filed 4 Nov 2016.